Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1.7K
TL;DR: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
read more
Abstract: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer
Christian Ruiz,David R Holz,Martin Oeggerli,Sandra Schneider,Irma M. Gonzales,Jeff Kiefer,Tobias Zellweger,Alexander Bachmann,Pasi A. Koivisto,Heikki Helin,Spyro Mousses,Michael T. Barrett,David O. Azorsa,Lukas Bubendorf +13 more
TL;DR: Vinculin is a major driving gene of the 10q22 amplification in prostate cancer and that vinculin overexpression might contribute to prostate cancer progression by enhancing tumour cell proliferation.
37
Aberrant expression of katanin p60 in prostate cancer bone metastasis
Xiangcang Ye,Yu Chen Lee,Michel Choueiri,Khoi Chu,Chih-Fen Huang,Wen-Wei Tsai,Ryuji Kobayashi,Christopher J. Logothetis,Li Yuan Yu-Lee,Sue Hwa Lin +9 more
TL;DR: Katanin p60 is a microtubules‐severing protein and is involved in microtubule cytoskeleton organization in both mitotic and non‐mitotic processes.
A genetic screen in Drosophila for regulators of human prostate cancer progression.
Saya Ito,Takashi Ueda,Akihisa Ueno,Hideo Nakagawa,Hidefumi Taniguchi,Naruhiro Kayukawa,Tsuneharu Miki +6 more
TL;DR: These findings suggest that the development of the Drosophila accessory gland and human prostate cancer cell growth and invasion are partly regulated through a common mechanism.
37
Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells.
Trine Engelbrecht Hybel,Dorothea Dietrichs,Jayashree Sahana,Thomas J. Corydon,Thomas J. Corydon,Mohamed Nassef,Markus Wehland,Marcus Krüger,Nils E. Magnusson,Johann Bauer,Kirsten Utpatel,Manfred Infanger,Daniela Grimm,Sascha Kopp +13 more
TL;DR: RPM-exposure of PC-3 cells induced changes in their morphology, cytoskeleton, and extracellular matrix protein synthesis, as well as in their focal adhesion complex and growth behavior.
37
A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer
TL;DR: Data show for the first time that simultaneous targeting of cytokine receptors with two ligands on the same molecule has pronounced anticancer advantages and in an animal model in which human DTEGF13 was highly effective in checking aggressive prostate tumor progression and was reasonably tolerated.
37